Non-invasive Biometric Monitoring in Nursing Homes to Fight COVID-19

CompletedOBSERVATIONAL
Enrollment

26

Participants

Timeline

Start Date

December 30, 2020

Primary Completion Date

April 30, 2021

Study Completion Date

June 9, 2021

Conditions
Covid19Community-Acquired Respiratory Tract Infection
Interventions
DEVICE

Observational measurement of biometric data. No change to health care provided.

"Emfit devices will be installed once after enrollment under each participant's mattress and left to record automatically without further intervention. The participants will wear their Biostrap wristbands consistently, ideally 24 hours a day, 7 days a week, for 2 months.~A virus panel will be upon enrollment (baseline) and then every two weeks (± 3 days, or on the closest convenient sampling day if the LTCF is testing all residents on the same day) for a maximum of 5 times during the two-month period. Using polymerase chain reaction or next generation sequencing, the virus panel will detect COVID-19 and 12 other common respiratory viruses that may cause similar symptoms and similar biometric signatures. These include influenza A and B, parainfluenza types 1 through 4, respiratory syncytial virus, non-COVID coronavirus, rhinovirus, adenovirus, bocavirus and metapneumovirus."

Trial Locations (1)

99301

Avalon Health & Rehabilitation Center, Pasco

All Listed Sponsors
lead

Health Stream Analytics, LLC

INDUSTRY

NCT04548895 - Non-invasive Biometric Monitoring in Nursing Homes to Fight COVID-19 | Biotech Hunter | Biotech Hunter